CalciMedica, Inc.

CALC Nasdaq SEC CIK 1534133
Follow CalciMedica Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$1.7M +78.5% vs same quarter last year
EPS, diluted −$0.24 +90.7% vs same quarter last year
Operating cash flow −$3.9M +19.2% vs same quarter last year
Operating income −$4.8M +15.4% vs same quarter last year
Net income by quarter
−$4.3M
−$5M
−$6M
−$7.8M
−$10.8M
$5M
−$7.7M
−$1.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
−$40M−$30M−$20M−$10M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$29.6M
FY24−$13.7M
FY23−$34.4M
FY22−$7.8M
FY21−$35.8M
FY20−$27.5M
FY19−$37M
FY18-
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$21.2M
FY24−$21.2M
FY23−$25.8M
FY22−$11.8M
FY21−$32M
FY20−$33.1M
FY19−$31.8M
FY18-